Adventrx
Pharmaceuticals About
Adventrx Pharmaceuticals ADVENTRX Pharmaceuticals, Inc.
is focused on introducing new technologies for anticancer and antiviral treatments
that improve the performance of existing drugs and address significant
problems such as drug resistance. The Company has three products in or moving
into clinical trials, all of which may qualify for the FDA's Fast Track Approval
status. CoFactor (5,10-methylenetetrahydrofolate) --metastatic
colorectal cancer patients. SELONE --drug-resistant cancers NIH
TRIAL -- FOR COFACTOR AND 5FU More
on Anika